サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421745

ワクチン受託製造市場、シェア、規模、動向、産業分析レポート：ワクチンタイプ別、用途別、プロセス別、地域別、セグメント別予測、2023年～2032年

Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type ; By Application; By Process; By Region; Segment Forecast, 2023- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ワクチン受託製造市場、シェア、規模、動向、産業分析レポート：ワクチンタイプ別、用途別、プロセス別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年12月23日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界のワクチン受託製造市場規模は2032年までに131億6,000万米ドルに達する見込みです。同レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

製薬・バイオ医薬品企業は、戦略的にコアコンピタンスを優先させ、価格競争の激化を乗り切ろうとしています。その結果、受託製造への傾斜が強まっています。

しかし、ワクチンの製造は、安全性、有効性、一貫性の保証に努める製造業者にとって複雑な課題となっています。ワクチン受託製造市場は、製造プロセス、製造施設の設立と運営、細胞株開拓、発酵、プロセスの改良、分析特性評価などを含む多様なサービスによって牽引されています。これらのサービスは総体的に、世界レベルでの市場の大幅な成長を牽引する極めて重要な役割を果たしています。

ワクチン接種は、ヒトと家畜の健康増進に重要な役割を果たしています。抗生物質への依存を減らすだけでなく、様々な病気に対する強力な抑止力としても機能します。重篤な病気や感染症から身を守るなど、予防接種には様々な利点があることが認識されるようになり、予防接種の取り組みや接種プログラムが広く呼びかけられています。これに伴い、製造には多額の資本が必要であるとの認識から、大手製薬企業はワクチン製造の分野でアウトソーシングを選択するようになっています。

しかし、資源が乏しい国では、ワクチン製造のための設備や熟練した労働力が不足しており、これが世界のワクチン受託製造市場の拡大を促す大きな要因となっています。さらに、EB66やGPExのような先進的な発現システムの導入と革新的な細胞培養培地プラットフォームが、市場成長の大きな支えとなっています。さらに、さまざまな国でCOVID-19の症例が急増していることから、ワクチン開発企業は製造受託機関（CMO）とのアウトソーシング契約に取り組むようになり、市場開拓のための前向きな軌道が形成されています。

ワクチン受託製造市場レポートハイライト

不活化ワクチン分野は、効率性の高さから予測期間中に最も速いCAGRが見込まれます。

2022年には、動物用ワクチン製造におけるCMOの利用拡大が主因となって、動物用セグメントが収益シェアで大きなシェアを占めました。

2022年、川下分野は技術の進歩と革新により最大の市場シェアを占めました。

2022年には、北米地域が最大の市場シェアを占めたが、これは技術の飛躍的な成長と研究開発投資の増加によるものです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のワクチン受託製造市場別洞察

  • ワクチン受託製造市場-プロセスのスナップショット
  • ワクチン受託製造市場力学
    • 促進要因と機会
      • ワクチンの需要の増加により、製品の需要が刺激されると予測
      • バイオ医薬品の進歩
    • 抑制要因と課題
      • 複雑な規制環境
  • PESTEL分析
  • ワクチン受託製造市場のプロセス動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のワクチン受託製造市場、ワクチンタイプ別

  • 主要調査結果
  • イントロダクション
  • 不活化ワクチン
  • DNAワクチン
  • 弱毒化ワクチン
  • トキソイドワクチン
  • サブユニットワクチン

第6章 世界のワクチン受託製造市場、用途別

  • 主要調査結果
  • イントロダクション
  • 人間
  • 動物

第7章 世界のワクチン受託製造市場、プロセス別

  • 主要調査結果
  • イントロダクション
  • 川上
  • 川下

第8章 地域の世界のワクチン受託製造市場

  • 主要調査結果
  • イントロダクション
    • ワクチン受託製造市場評価、地域別、2019～2032年
  • ワクチン受託製造市場-北米
    • 北米：ワクチン受託製造市場、ワクチンタイプ別、2019～2032年
    • 北米：ワクチン受託製造市場、プロセス別、2019～2032年
    • 北米：ワクチン受託製造市場、用途別、2019～2032年
    • ワクチン受託製造市場-米国
    • ワクチン受託製造市場-カナダ
  • ワクチン受託製造市場-欧州
    • 欧州：ワクチン受託製造市場、ワクチンタイプ別、2019～2032年
    • 欧州：ワクチン受託製造市場、プロセス別、2019～2032年
    • 欧州：ワクチン受託製造市場、用途別、2019～2032年
    • ワクチン受託製造市場-英国
    • ワクチン受託製造市場-フランス
    • ワクチン受託製造市場-ドイツ
    • ワクチン受託製造市場-イタリア
    • ワクチン受託製造市場-スペイン
    • ワクチン受託製造市場-オランダ
    • ワクチン受託製造市場-ロシア
  • ワクチン受託製造市場-アジア太平洋
    • アジア太平洋：ワクチン受託製造市場、ワクチンタイプ別、2019～2032年
    • アジア太平洋：ワクチン受託製造市場、プロセス別、2019～2032年
    • アジア太平洋：ワクチン受託製造市場、用途別、2019～2032年
    • ワクチン受託製造市場-中国
    • ワクチン受託製造市場-インド
    • ワクチン受託製造市場-マレーシア
    • ワクチン受託製造市場-日本
    • ワクチン受託製造市場-インドネシア
    • ワクチン受託製造市場-韓国
  • ワクチン受託製造市場-中東・アフリカ
    • 中東・アフリカ：ワクチン受託製造市場、ワクチンタイプ別、2019～2032年
    • 中東・アフリカ：ワクチン受託製造市場、プロセス別、2019～2032年
    • 中東・アフリカ：ワクチン受託製造市場、用途別、2019～2032年
    • ワクチン受託製造市場-サウジアラビア
    • ワクチン受託製造市場-アラブ首長国連邦
    • ワクチン受託製造市場-イスラエル
    • ワクチン受託製造市場-南アフリカ
  • ワクチン受託製造市場-ラテンアメリカ
    • ラテンアメリカ：ワクチン受託製造市場、ワクチンタイプ別、2019～2032年
    • ラテンアメリカ：ワクチン受託製造市場、プロセス別、2019～2032年
    • ラテンアメリカ：ワクチン受託製造市場、用途別、2019～2032年
    • ワクチン受託製造市場-メキシコ
    • ワクチン受託製造市場-ブラジル
    • ワクチン受託製造市場-アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AGC Biologics
  • Catalent, Inc.
  • Charles River Laboratories
  • Emergent BioSolutions
  • Fujifilm Diosynth Biotechnologies
  • IDT Biologika GmbH
  • KBI Biopharma
  • Lonza Group
  • Merck KGaA
  • Recipharm AB
  • Richter-Helm BioLogics GmbH & Co. KG
  • Seqirus（CSL Limited）
  • WuXi Biologics
  • Samsung Biologics
図表

List of Tables

  • Table 1 Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 2 Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 4 Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 6 North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 8 U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 11 Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 14 Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 17 UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 18 UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 20 France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 21 France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 23 Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 26 Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 29 Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 35 Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 41 China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 42 China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 44 India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 45 India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 50 Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 56 South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 65 UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 68 Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 71 South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 74 Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 77 Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 80 Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • Table 83 Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Vaccine Contract Manufacturing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Vaccine Contract Manufacturing Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Vaccine Type
  • Figure 9. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Process
  • Figure 11. Global Vaccine Contract Manufacturing Market, by Process, 2022 & 2032 (USD Billion)
  • Figure 12. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Vaccine Contract Manufacturing Market
目次
Product Code: PM4069

The global vaccine contract manufacturing market size is expected to reach USD 13.16 billion by 2032, according to a new study by Polaris Market Research. The report "Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type (Inactivated Vaccine, DNA Vaccines, Attenuated Vaccine, Toxoid Vaccines, Subunit Vaccines); By Application; By Process; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical and biopharmaceutical companies are strategically prioritizing their core competencies to navigate the escalating price pressures. Consequently, there is a growing inclination towards contract manufacturing.

However, vaccine production presents a complex challenge for manufacturers as they strive to guarantee safety, effectiveness, and consistency. The vaccine contract manufacturing market is driven by a diverse range of services encompassing production processes, the establishment and operation of manufacturing facilities, cell line development, fermentation, process refinement, and analytical characterization. These services collectively play a pivotal role in driving the market's substantial growth on a worldwide level.

Vaccination plays an important role in enhancing both human and veterinary health. It not only diminishes reliance on antibiotics but also serves as a potent deterrent against various diseases. The escalating recognition of its manifold advantages, which include safeguarding against severe illnesses and infectious conditions, is fueling the call for widespread immunization initiatives and inoculation programs. In tandem with this, the cognizance of the substantial capital outlay needed for production has prompted major pharmaceutical entities to opt for outsourcing in the realm of vaccine manufacturing.

However, in low-resource countries, the shortage of equipment and proficient labor for vaccine production is a significant factor driving the expansion of the global vaccine contract manufacturing market. Additionally, the introduction of advanced expression systems such as EB66 and GPEx, along with innovative cell culture media platforms, is providing substantial support for market growth. Furthermore, the surging instances of COVID-19 in various nations have prompted vaccine developers to engage in outsourcing agreements with Contract Manufacturing Organizations (CMOs), fostering a positive trajectory for market advancement.

Vaccine Contract Manufacturing Market Report Highlights

The Inactivated Vaccine segment is expected to witness the fastest CAGR during the forecast period on account of better efficiency.

The veterinary segment held a significant share in revenue share in 2022, which is mainly driven by increased utilization of CMOs in the production of animal vaccinations.

In 2022, the downstream segment held the largest market share due to technological advancements and innovation.

In 2022, the North American region held the largest market share, owing to exponential growth in technology and rising R&D investments.

The global key market players include: Fujifilm Diosynth Biotechnologies, IDT Biologika GmbH, KBI Biopharma, Lonza Group, Merck KGaA, and more.

Polaris Market Research has segmented the vaccine contract manufacturing market report based on vaccine type, application, process, and region:

Vaccine Contract Manufacturing, Vaccine Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Inactivated Vaccine
  • DNA Vaccines
  • Attenuated Vaccine
  • Toxoid Vaccines
  • Subunit Vaccines

Vaccine Contract Manufacturing, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Human
  • Veterinary

Vaccine Contract Manufacturing, Process Outlook (Revenue - USD Billion, 2019 - 2032)

  • Upstream
  • Downstream

Vaccine Contract Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Vaccine Contract Manufacturing Market Insights

  • 4.1. Vaccine Contract Manufacturing Market - Process Snapshot
  • 4.2. Vaccine Contract Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased demand for vaccines is projected to spur the product demand
      • 4.2.1.2. Biopharmaceutical Advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex Regulatory Environment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Vaccine Contract Manufacturing Market Process Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Vaccine Contract Manufacturing Market, by Vaccine Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
  • 5.3. Inactivated Vaccine
    • 5.3.1. Global Vaccine Contract Manufacturing Market, by Inactivated Vaccine, by Region, 2019-2032 (USD Billion)
  • 5.4. DNA Vaccines
    • 5.4.1. Global Vaccine Contract Manufacturing Market, by DNA Vaccines, by Region, 2019-2032 (USD Billion)
  • 5.5. Attenuated Vaccine
    • 5.5.1. Global Vaccine Contract Manufacturing Market, by Attenuated Vaccine, by Region, 2019-2032 (USD Billion)
  • 5.6. Toxoid Vaccines
    • 5.6.1. Global Vaccine Contract Manufacturing Market, by Toxoid Vaccines, by Region, 2019-2032 (USD Billion)
  • 5.7. Subunit Vaccines
    • 5.7.1. Global Vaccine Contract Manufacturing Market, by Subunit Vaccines, by Region, 2019-2032 (USD Billion)

6. Global Vaccine Contract Manufacturing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Human
    • 6.3.1. Global Vaccine Contract Manufacturing Market, by Human, by Region, 2019-2032 (USD Billion)
  • 6.4. Veterinary
    • 6.4.1. Global Vaccine Contract Manufacturing Market, by Veterinary, by Region, 2019-2032 (USD Billion)

7. Global Vaccine Contract Manufacturing Market, by Process

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
  • 7.3. Upstream
    • 7.3.1. Global Vaccine Contract Manufacturing Market, by Upstream, By Region, 2019-2032 (USD Billion)
  • 7.4. Downstream
    • 7.4.1. Global Vaccine Contract Manufacturing Market, by Downstream, By Region, 2019-2032 (USD Billion)

8. Global Vaccine Contract Manufacturing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Vaccine Contract Manufacturing Market - North America
    • 8.3.1. North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.3.3. North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Vaccine Contract Manufacturing Market - U.S.
      • 8.3.4.1. U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Vaccine Contract Manufacturing Market - Canada
      • 8.3.5.1. Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Vaccine Contract Manufacturing Market - Europe
    • 8.4.1. Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Vaccine Contract Manufacturing Market - UK
      • 8.4.4.1. UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Vaccine Contract Manufacturing Market - France
      • 8.4.5.1. France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Vaccine Contract Manufacturing Market - Germany
      • 8.4.6.1. Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Vaccine Contract Manufacturing Market - Italy
      • 8.4.7.1. Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Vaccine Contract Manufacturing Market - Spain
      • 8.4.8.1. Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Vaccine Contract Manufacturing Market - Netherlands
      • 8.4.9.1. Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Vaccine Contract Manufacturing Market - Russia
      • 8.4.10.1. Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Vaccine Contract Manufacturing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Vaccine Contract Manufacturing Market - China
      • 8.5.4.1. China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Vaccine Contract Manufacturing Market - India
      • 8.5.5.1. India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Vaccine Contract Manufacturing Market - Malaysia
      • 8.5.6.1. Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Vaccine Contract Manufacturing Market - Japan
      • 8.5.7.1. Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Vaccine Contract Manufacturing Market - Indonesia
      • 8.5.8.1. Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Vaccine Contract Manufacturing Market - South Korea
      • 8.5.9.1. South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Vaccine Contract Manufacturing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Vaccine Contract Manufacturing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Vaccine Contract Manufacturing Market - UAE
      • 8.6.5.1. UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Vaccine Contract Manufacturing Market - Israel
      • 8.6.6.1. Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Vaccine Contract Manufacturing Market - South Africa
      • 8.6.7.1. South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Vaccine Contract Manufacturing Market - Latin America
    • 8.7.1. Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Vaccine Contract Manufacturing Market - Mexico
      • 8.7.4.1. Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Vaccine Contract Manufacturing Market - Brazil
      • 8.7.5.1. Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Vaccine Contract Manufacturing Market - Argentina
      • 8.7.6.1. Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AGC Biologics
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Catalent, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Charles River Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Emergent BioSolutions
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fujifilm Diosynth Biotechnologies
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. IDT Biologika GmbH
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. KBI Biopharma
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lonza Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck KGaA
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Recipharm AB
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Richter-Helm BioLogics GmbH & Co. KG
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Seqirus (CSL Limited)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. WuXi Biologics
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Samsung Biologics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development